MENLO PARK, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the second quarter ended June 30, 2022.
Recent Business Highlights
- Generated total revenue of $17.2 million in the second quarter of 2022, an increase of 37% compared to the prior year period and 16% from the first quarter
- Expanded total gross margin to 84% in the second quarter of 2022 versus 82% in the prior year period
- Increased the number of facilities ordering the OMNI® Surgical System from 811 in the first quarter of 2022 to 875 in the second quarter of 2022, and the installed base of TearCare® System facilities from 635 on March 31, 2022 to 762 on June 30, 2022
- Maintained continued excellence in Surgical…